0 Items
Select Page

Parvovirus

For most healthy people, parvovirus B19 infection causes a mild, self-limiting illness which is followed by life-long immunity. Infection is common in developed countries, where approximately 15% of pre-school children, 50% of adults, and 85% of elderly people show evidence of past infection.

The Native Antigen Company offers recombinant Parvovirus virus-like particles, expressing VP2 antigen in support of research into parvovirus biology and infection.

Parvovirus Background

Parvovirus B19 (B19V) is a small, non-enveloped, single-stranded DNA virus. Parvovirus belongs to the genus Erythroparvovirus within the Parvovirinae subfamily and is a member of the Parvoviridae family of viruses. B19V is highly infectious and is commonly transmitted between humans via infected respiratory secretions. The virus can also be transmitted through B19V infected blood products, transplant material, and from mother-to-foetus during pregnancy (CDC).

B19V infection commonly occurs in childhood, but can occur in some adults that have not been previously exposed to the virus. In healthy individuals, B19V causes erythema infectiosum, a typically mild disease, also known as ‘fifth disease’. The disease is characterised by a facial rash, which can later appear on the trunk and limbs, and is associated with mild fever and cold-like symptoms. In some adult cases, patients may present with joint pain and swelling that can continue for several months. Other symptoms of B19V infection include anaemia in immunocompromised patients, and a transient decrease in erythropoiesis in cases of sickle-cell anaemia (Rogo, LD. et al).

Diagnosis of B19V infection is generally performed using enzyme-linked immunosorbent assays, or ELISAs, to detect B19V-specific IgM or IgG antibodies in patient sera. Currently, there is no licenced vaccine available or specific antiviral therapy for the treatment of B19V infection.

References

  1. Centers for disease control and prevention: Parvovirus and Fifth disease
  2. Rogo, LD et. al. (2014). Human parvovirus B19: a review. Acta Virol.58:199-213.

Parvovirus Antigens

Parvovirus VP2 protein is a unique reagent that has been developed in response to the need for a highly pure and correctly assembled parvovirus antigen.

Parvovirus VP2 is produced in the form of virus-like particles (VLP) in human cell lines using state-of-the-art expression techniques. Concentration and purification are then performed by a series of ultracentrifuge and precipitation methods, which result in VLPs of exceptional quality and purity.

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

Why We Need Antigen and Antibody Tests for COVID-19

RT-PCR is the workhorse of viral diagnosis and has been invaluable in COVID-19 case confirmation and isolation guidance. However, while fast and sensitive, PCR suffers from some inherent drawbacks that limit it to diagnosis during the acute phase of infection. To...

Gonorrhea: What’s Currently in the Clinical Pipeline?

This article was written by our friends at Infectious Diseases Hub, a free-to-access website that aims to deliver up-to-date, essential research and information on all aspects of microbiology, virology, mycology and parasitology – from bench to bedside....

Novel Coronavirus Antigens Now Available

The Native Antigen Company is now offering recombinant S1 and S2 glycoproteins for SARS-CoV-2 (Covid-19) in response to urgent demand. These reagents are suitable for use in basic research and the development of diagnostics and vaccines.These antigens have been...

The Why and How of Protein Conjugation

In this blog, Lead Assay Development Scientist, Toni Ertl discusses the basics of protein conjugation and introduces our new range of conjugation kits for the labelling of antigens and antibodies.Detecting Proteins If you’re trying to detect or measure the presence...

Going Viral: Why We Need New Diagnostics For a Safe and Effective Dengue Vaccine

This article is taken from European Biopharmaceutical Review January 2020, pages 44-46. © Samedan Ltd.The Dengue VirusDengue is the world’s most prevalent and consequential arboviral disease. Current estimates indicate that as many as 390 million dengue infections...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

5 + 5 =

Live Customer Feedback

Join our mailing list

* indicates required